BACKGROUND: People in sub-Saharan Africa frequently consult traditional healers before reaching the government health services (GHS). This can lead to delays in starting effective anti-tuberculosis chemotherapy. To our knowledge, no studies have shown a direct relationship between visiting traditional healers, increased morbidity and death from TB. METHODS: All patients starting on anti-tuberculosis chemotherapy at a rural hospital in South Africa in 2003 were included in the study. TB nurses interviewed the patients and established how long they had had symptoms before treatment was started, whether they had visited traditional healers before coming to the hospital, their performance status and, later, whether they had died. RESULTS: Of 133 patients, those who attended a traditional healer took longer to access anti-tuberculosis chemotherapy (median 90 days, range 0-210) than those who went directly to the GHS (median 21, range 0-120). Patients who visited a traditional healer had worse performance status (P < 0.001), and were more likely to die (24/77 [31%] vs. 4/33 [12%], P = 0.04). CONCLUSION: Treatment delay due to visiting traditional healers can have dire consequences for patients with TB. Efforts are required to engage with health care practitioners outside the government sector to improve the prospects for patients with TB.
BACKGROUND:People in sub-Saharan Africa frequently consult traditional healers before reaching the government health services (GHS). This can lead to delays in starting effective anti-tuberculosis chemotherapy. To our knowledge, no studies have shown a direct relationship between visiting traditional healers, increased morbidity and death from TB. METHODS: All patients starting on anti-tuberculosis chemotherapy at a rural hospital in South Africa in 2003 were included in the study. TB nurses interviewed the patients and established how long they had had symptoms before treatment was started, whether they had visited traditional healers before coming to the hospital, their performance status and, later, whether they had died. RESULTS: Of 133 patients, those who attended a traditional healer took longer to access anti-tuberculosis chemotherapy (median 90 days, range 0-210) than those who went directly to the GHS (median 21, range 0-120). Patients who visited a traditional healer had worse performance status (P < 0.001), and were more likely to die (24/77 [31%] vs. 4/33 [12%], P = 0.04). CONCLUSION: Treatment delay due to visiting traditional healers can have dire consequences for patients with TB. Efforts are required to engage with health care practitioners outside the government sector to improve the prospects for patients with TB.
Authors: P Pungrassami; A M Kipp; P W Stewart; V Chongsuvivatwong; R P Strauss; A Van Rie Journal: Int J Tuberc Lung Dis Date: 2010-02 Impact factor: 2.373
Authors: Delia Boccia; James Hargreaves; Helen Ayles; Katherine Fielding; Musonda Simwinga; Peter Godfrey-Faussett Journal: Am J Trop Med Hyg Date: 2009-06 Impact factor: 2.345
Authors: Ndeindo Ndeikoundam Ngangro; Doudeadoum Ngarhounoum; Mosurel N Ngangro; Ngakoutou Rangar; Mahinda G Siriwardana; Virginie Halley des Fontaines; Pierre Chauvin Journal: BMC Public Health Date: 2012-07-09 Impact factor: 3.295
Authors: Sven Gudmund Hinderaker; Simon Madland; Martin Ullenes; Donald A Enarson; Id Rusen; Deudatus Kamara Journal: BMC Public Health Date: 2011-05-12 Impact factor: 3.295
Authors: Alyssa Finlay; Joey Lancaster; Timothy H Holtz; Karin Weyer; Abe Miranda; Martie van der Walt Journal: BMC Public Health Date: 2012-01-20 Impact factor: 3.295
Authors: Paul Mee; Ryan G Wagner; Francesc Xavier Gómez-Olivé; Chodziwadziwa Kabudula; Kathleen Kahn; Sangeetha Madhavan; Mark Collinson; Peter Byass; Stephen M Tollman Journal: BMC Complement Altern Med Date: 2014-12-17 Impact factor: 3.659
Authors: Marleen Vree; Nguyen T Huong; Bui D Duong; Nguyen V Co; Dinh N Sy; Frank G Cobelens; Martien W Borgdorff Journal: BMC Public Health Date: 2007-08-16 Impact factor: 3.295